Jennifer Bath
Chief Executive Officer at IMMUNOPRECISE ANTIBODIES LTD.
Net worth: 297 089 $ as of 2024-04-29
Jennifer Bath active positions
Companies | Position | Start | End |
---|---|---|---|
IMMUNOPRECISE ANTIBODIES LTD. | Director/Board Member | 2018-05-23 | - |
Chief Executive Officer | 2018-02-20 | - | |
President | 2018-02-20 | - |
Career history of Jennifer Bath
Former positions of Jennifer Bath
Companies | Position | Start | End |
---|---|---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Corporate Officer/Principal | 2015-06-30 | 2018-01-31 |
Concordia University | Corporate Officer/Principal | 2005-04-30 | 2015-07-31 |
Concordia College Global Vaccine Institute | Director/Board Member | 2009-08-31 | 2015-07-31 |
Founder | 2009-08-31 | 2015-07-31 |
Training of Jennifer Bath
North Dakota State University | Doctorate Degree |
University of Kansas | Undergraduate Degree |
Statistics
International
United States | 5 |
Canada | 3 |
Operational
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectoral
Consumer Services | 5 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
IMMUNOPRECISE ANTIBODIES LTD. | Health Technology |
Private companies | 1 |
---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Health Technology |
- Stock Market
- Insiders
- Jennifer Bath
- Experience